NDC11 73614041703
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 73614-0417-03 | 73614-0417 |
| 73614-0417-3 | 73614-0417 |
| 73614-417-03 | 73614-417 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Orapaz | CEPHALEXIN, IBUPROFEN, CHLORHEXIDINE GLUCONATE | Brisk Pharmaceuticals | 2de0b332-58a3-0bb4-e063-6394a90a1a45 | 2025-02-11 | 73614-417-03 73614-417 73614041703 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.